YSB (HKSE:09885) Debt-to-Equity : 0.10 (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is YSB Debt-to-Equity?

YSB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$110 Mil. YSB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$139 Mil. YSB's Total Stockholders Equity for the quarter that ended in Dec. 2024 was HK$2,476 Mil. YSB's debt to equity for the quarter that ended in Dec. 2024 was 0.10.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for YSB's Debt-to-Equity or its related term are showing as below:

HKSE:09885' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.1 Med: -0.04 Max: 0.11
Current: 0.1

During the past 5 years, the highest Debt-to-Equity Ratio of YSB was 0.11. The lowest was -0.10. And the median was -0.04.

HKSE:09885's Debt-to-Equity is ranked better than
78.47% of 562 companies
in the Healthcare Providers & Services industry
Industry Median: 0.44 vs HKSE:09885: 0.10

YSB Debt-to-Equity Historical Data

The historical data trend for YSB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Debt-to-Equity Chart

YSB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

-0.10

-0.06

-0.04

0.11

0.10

YSB Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial			-0.04	0.10	0.11	0.11	0.10

Competitive Comparison of YSB's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, YSB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where YSB's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

YSB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

YSB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(110.481	+	138.836)	/	2475.999
	=	0.10

YSB's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(110.481	+	138.836)	/	2475.999
	=	0.10

YSB (HKSE:09885) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

YSB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of YSB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

B1S:Germany

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Zhang Buzhen	2501 Other
Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V, L.p.	2101 Beneficial owner
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
Shleifer Scott	2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd.	2201 Interest of corporation controlled by you
Tiger Global Management, Llc	2102 Investment manager
Tiger Global Pip Performance Xi, L.p.	2201 Interest of corporation controlled by you
Tiger Global Private Investment Partners Xi, L.p.	2101 Beneficial owner
Coleman Iii Charles	2201 Interest of corporation controlled by you
Miyt Worldwide Limited	2201 Interest of corporation controlled by you
Tmf (cayman) Ltd.	2301 Trustee
Internet Fund V Pte. Ltd.	2306 Nominee for another person
Miyt Holdings Limited	2101 Beneficial owner

YSB Headlines

No Headlines